Skip to main content
SpringerLink
Log in

Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

The concentration of circulating homocysteine has been associated with a variety of diseases, including myocardial infarction, stroke, venous thrombosis and cognitive decline. Genetic variation has been demonstrated to play an important role in determining plasma homocysteine, however, the genes involved are incompletely understood. Ligation of the transcription factor peroxisome proliferator-activated gamma (PPARG) has been demonstrated to lower plasma homocysteine. We examined the association of two sequence variations in PPARG with plasma concentrations of homocysteine in a population-based study of 3,875 elderly men. PPARG c.34G > C and PPARG c.1347C > T sequence variations were determined by real-time quantitative PCR and related to logarithm transformed homocysteine concentrations using linear regression, adjusting for the co-variants age, renal function, smoking, coronary heart disease, waist to hip ratio, diabetes, hypertension and MTHFR g.677C > T sequence variation. Median plasma homocysteine concentration was 10% higher in men who were homozygous for the rare allelic variation in PPARG c.34G > C and PPARG c.1347C > T by comparison to those who had wild type sequence variation. PPARG c.1347C > T (β = 0.038, P = 0.01 recessive model; β = 0.036, P = 0.02 dominant model) sequence variation was positively associated with homocysteine concentration after adjusting for co-variants. The two PPARG sequence variations were in linkage disequilibrium and the common haplotype was associated with lower plasma homocysteine (P = 0.005). Our findings demonstrate a new genotypic association with plasma homocysteine. Replication will be required in other cohorts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • B-Vitamin Treatment Trialists’ Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151:282–287

    Article  CAS  Google Scholar 

  • Bathum L, Petersen I, Christiansen L, Konieczna A, Sorensen TI, Kyvik KO (2007) Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clin Chem 53:971–979

    Article  PubMed  CAS  Google Scholar 

  • Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B (1994) Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633–641

    Article  PubMed  CAS  Google Scholar 

  • Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 29:3–20

    Article  PubMed  CAS  Google Scholar 

  • Cesari M, Zanchetta M, Burlina A, Pedon L, Maiolino G, Sticchi D, Pessina AC, Rossi GP (2005) Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 25:115–121

    PubMed  CAS  Google Scholar 

  • Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287

    Article  PubMed  CAS  Google Scholar 

  • den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3:292–299

    Article  Google Scholar 

  • den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM (2007) Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 109:139–144

    Article  CAS  Google Scholar 

  • Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J (2007) Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat (in press)

  • Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113

    Article  PubMed  CAS  Google Scholar 

  • Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE (2007) Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 27:655–660

    Article  PubMed  CAS  Google Scholar 

  • Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento area Latino study on aging. Am J Clin Nutr 85:511–517

    PubMed  CAS  Google Scholar 

  • Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015–2022

    Article  Google Scholar 

  • Jamrozik K, Norman PE, Spencer CA, Parsons RW, Tuohy R, Lawrence-Brown MM, Dickinson JA (2000) Screening for abdominal aortic aneurysm: lessons from a population-based study. Med J Aust 173:345–350

    PubMed  CAS  Google Scholar 

  • Janosikova B, Zavadakova P, Kozich V (2005) Single-nucleotide polymorphisms in genes relating to homocysteine metabolism: how applicable are public SNP databases to a typical European population? Eur J Hum Genet 13:86–95

    Article  PubMed  CAS  Google Scholar 

  • Jaziri R, Lobbens S, Aubert R, Pean F, Lahmidi S, Vaxillaire M, Porchay I, Bellili N, Tichet J, Balkau B, Froguel P, Marre M, Fumeron F; DESIR Study Group (2006) The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the data from an epidemiological study on the insulin resistance syndrome (DESIR) study. Diabetes 55:1157–1162

    Article  PubMed  CAS  Google Scholar 

  • Jee SH, Song KS, Shim WH, Kim HK, Suh I, Park JY, Won SY, Beaty TH (2002) Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Hum Genet 111:128–135

    Article  PubMed  CAS  Google Scholar 

  • Kullo IJ, Ding K, Boerwinkle E, Turner ST, Mosley TH Jr, Kardia SL, de Andrade M (2006) Novel genomic loci influencing plasma homocysteine levels. Stroke 37:1703–1709

    Article  PubMed  CAS  Google Scholar 

  • Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182

    Article  PubMed  CAS  Google Scholar 

  • Loscalzo J (2006) Homocysteine trials–clear outcomes for complex reasons. N Engl J Med 354:1629–1632

    Article  PubMed  CAS  Google Scholar 

  • McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049

    Article  PubMed  CAS  Google Scholar 

  • Murthy SN, Obregon DF, Chattergoon NN, Fonseca NA, Mondal D, Dunne JB, Diez JG, Jeter JR Jr, Kadowitz PJ, Agrawal KC, McNamara DB, Fonseca VA (2005) Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague–Dawley rats fed a high methionine diet. Metabolism 54:645–652

    Article  PubMed  CAS  Google Scholar 

  • Norman PE, Jamrozik K, Lawrence-Brown MM, Le M, Spencer CA, Tuohy R, Parsons R, Dickinson JA (2004) Impact of screening on mortality from abdominal aortic aneurysm: results of a large, population-based randomised controlled trial. BMJ 329:1259–1262

    Article  PubMed  Google Scholar 

  • Norton K, Whittingham N, Carter L, Kerr D, Gore C, Marfell-Jones M (2000) Measurement techniques in anthropometry. In: Norton K, Olds T (eds) Anthropometrica. UNSW, Sydney, pp 27–75

    Google Scholar 

  • Orio F Jr, Matarese G, Di Biase S, Palomba S, Labella D, Sanna V, Savastano S, Zullo F, Colao A, Lombardi G (2003) Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab 88:5887–5892

    Article  PubMed  CAS  Google Scholar 

  • Reed T, Malinow MR, Christian JC, Upson B (1991) Estimates of heritability of plasma homocyst(e)ine levels in aging adult male twins. Clin Genet 39:425–428

    Article  PubMed  CAS  Google Scholar 

  • Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC (2004) Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan study. Stroke 35:2263–2269

    Article  PubMed  CAS  Google Scholar 

  • Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND (2007) Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complications 21:118–123

    Article  PubMed  Google Scholar 

  • Sharma AM, Staels B (2007) Peroxisome proliferator-activated receptor gamma and adipose tissue—understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92:386–395

    Article  PubMed  CAS  Google Scholar 

  • Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordonez-Llanos J, Martin-Campos JM, Lathrop M, Stone W, Blangero J, Fontcuberta J (2005) A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 76:925–933

    Article  PubMed  CAS  Google Scholar 

  • Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrieres J, Ducimetiere P, Patterson CC, Kee F, Yarnell JW, Evans A; PRIME Study Group (2007) Homocysteine and coronary heart disease risk in the PRIME study. Atherosclerosis 191:90–97

    Article  PubMed  CAS  Google Scholar 

  • Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc Res 44:588–594

    Article  PubMed  CAS  Google Scholar 

  • Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR (1997) Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241:270–274

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors extend their thanks to the participants and staff involved in the Western Australian AAA Screening Study and Health In Men Study. Funding from the National Institute of Health, USA (RO1 HL080010-01) and NHMRC (project grant 379600) supported this work. JG and PEN hold Practitioner Fellowships from the NHMRC, Australia (431503 and 45805).

Author information

Authors and Affiliations

  1. The Vascular Biology Unit, Department of Surgery, School of Medicine, James Cook University, Townsville, QLD, 4811, Australia

    Jonathan Golledge

  2. School of Surgery and Pathology, University of Western Australia, Fremantle Hospital, Fremantle, WA, 6959, Australia

    Paul E. Norman

Authors
  1. Jonathan Golledge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul E. Norman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Golledge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Golledge, J., Norman, P.E. Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study. Hum Genet 123, 35–40 (2008). https://doi.org/10.1007/s00439-007-0446-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-007-0446-8

Keywords

Search

Navigation